Loading clinical trials...
Loading clinical trials...
The use of nasogastric (NG) decompression after pancreaticoduodenectomy (PD) is a current practice. NG tube is associated with a high rate of morbidity including pulmonary morbidity, delayed gastric e...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Rennes University Hospital
NCT07514637 · Patients Who Undergo Pancreaticoduodenectomy
NCT07132541 · Pancreaticoduodenectomy, Postoperative Pancreatic Fistula, and more
NCT07038161 · Pancreaticoduodenectomy, Distal Pancreatectomy, and more
NCT05581017 · Surgical Site Infection, Pancreaticoduodenectomy, and more
NCT06300801 · Pancreatic Fistula After Pancreaticoduodenectomy, C-Reactive Protein, and more
Centre Hospitalier Universitaire Rennes Pontchaillou
Rennes
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions